{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {
    "id": "N9vTMvwrxXNP"
   },
   "outputs": [],
   "source": [
    "from langchain.document_loaders import DirectoryLoader, PyPDFLoader\n",
    "from langchain.vectorstores import Pinecone\n",
    "from langchain_pinecone import PineconeVectorStore\n",
    "from pinecone import Pinecone as PC\n",
    "from pinecone import ServerlessSpec\n",
    "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
    "import os\n",
    "import glob\n",
    "from sentence_transformers import SentenceTransformer\n",
    "from langchain.embeddings import HuggingFaceEmbeddings\n",
    "from langchain.document_loaders import FileSystemBlobLoader\n",
    "from langchain.document_loaders.generic import GenericLoader\n",
    "from langchain.document_loaders.parsers import PyPDFParser\n",
    "import time\n",
    "import numpy as np\n",
    "from sklearn.decomposition import PCA\n",
    "import matplotlib.pyplot as plt\n",
    "import uuid\n",
    "from openai import OpenAI #Deprecated because i can't use his API(needs money)\n",
    "from ollama import Client"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {
    "id": "89s2yDEFrWXW"
   },
   "outputs": [],
   "source": [
    "#gerar n versoes da pergunta\n",
    "#criar novos docs a partir do artigo, categorizados"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "bk5FY2u4oojf"
   },
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {
    "id": "hdVsNYrWyHxA"
   },
   "outputs": [],
   "source": [
    "loader = DirectoryLoader(\n",
    "    \"./rag-projeto/data\",\n",
    "    glob=\"*.pdf\",\n",
    "    loader_cls=PyPDFLoader\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {
    "id": "abdDfixwz_dl"
   },
   "outputs": [],
   "source": [
    "docs = loader.load()\n",
    "\n",
    "text_splitter = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=500,  # Tamanho máximo de cada pedaço\n",
    "    chunk_overlap=50 # Sobreposição entre pedaços\n",
    ")\n",
    "docs_splitted = text_splitter.split_documents(docs)\n",
    "\n",
    "texts = [doc.page_content for doc in docs_splitted]\n",
    "#criar ID para rastrear os vetores\n",
    "ids = [str(uuid.uuid4()) for _ in range(len(texts))]\n",
    "#Apaga todos os vetores mas mantem o index criado\n",
    "#index.delete(delete_all=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {
    "id": "hJ4qPs_s1L39"
   },
   "outputs": [],
   "source": [
    "\n",
    "os.environ['PINECONE_API_KEY'] = 'pcsk_6JsENF_EkUKdhWBGJXSsKsbKdU2E5HAuGGq8AvfAvaCjFYj2BJUBxgEPq9GHQYMk2wK6ST'\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {
    "id": "uppKVAMgcpoB",
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "model = SentenceTransformer('sentence-transformers/paraphrase-multilingual-MiniLM-L12-v2')\n",
    "embeddings = model.encode(texts, show_porgress_bar=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {
    "id": "TzFrDhP23CIH"
   },
   "outputs": [],
   "source": [
    "index_name = \"rag\"\n",
    "pc = PC(api_key=\"pcsk_6JsENF_EkUKdhWBGJXSsKsbKdU2E5HAuGGq8AvfAvaCjFYj2BJUBxgEPq9GHQYMk2wK6ST\")\n",
    "index = pc.Index(index_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {
    "id": "mrG8oFjW4V0P"
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'dimension': 384,\n",
       " 'index_fullness': 0.0,\n",
       " 'metric': 'cosine',\n",
       " 'namespaces': {'': {'vector_count': 7544}},\n",
       " 'total_vector_count': 7544,\n",
       " 'vector_type': 'dense'}"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "embedder = HuggingFaceEmbeddings(\n",
    "    model_name=\"sentence-transformers/paraphrase-multilingual-MiniLM-L12-v2\", cache_folder=\"./ModeltoEmbedding\"\n",
    ")\n",
    "#texts eh uma lista de strings onde cada string é um documento.Essa função gera os embeddings\n",
    "embeddings= embedder.embed_documents(texts)\n",
    "# Associar os embeddings com seus IDs\n",
    "vectors = [(ids[i], embeddings[i]) for i in range(len(embeddings))]\n",
    "# Inserir os embeddings no Pinecone (upsert)\n",
    "index.upsert(vectors=vectors)\n",
    "\n",
    "#vectorstore = PineconeVectorStore.from_documents(docs_splitted, embedder, index_name=index_name)\n",
    "index.describe_index_stats()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {
    "id": "IJfFBtIg4uzv"
   },
   "outputs": [],
   "source": [
    "query = \"Quais os Principais Tipos de Diabetes?\"\n",
    "\n",
    "\n",
    "#Funçao do pinecone que já realiza a busca\n",
    "# similar_docs = vectorstore.similarity_search(query, k=5)\n",
    "#função para pegar o embedding do query\n",
    "query_embedding = embedder.embed_query(query)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "bgl2SAUl41A4",
    "outputId": "7122b530-fa84-4286-ff52-845afe2510fe"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<pinecone.data.index.Index object at 0x7bb4d80ec250>\n"
     ]
    }
   ],
   "source": [
    "\n",
    "#Resultado do metodo de busca padrao.\n",
    "# similar_docs\n",
    "print(index)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Similaridade: 0.7803\n",
      "Documento: \u0000\u0000\u0000\u0000Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for\n",
      "the classi\u0000cation and prediction of diabetes. Diabetes Care. 2011 Jan;34(1)\u000084-\n",
      "9. doi: 10.2337/dc10-1235. \n",
      "\u0000\u0000\u0000\u0000Kumar PR, Bhansali A, Ravikiran M, Bhansali S, Dutta P, Thakur JS, et al. Utility\n",
      "of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-\n",
      "based study. J Clin Endocrinol Metab. 2010 Jun 1;95(6)\u00002832–5. \n",
      "\u0000\u0000\u0000\u0000Kramer CK, Araneta MRG, Barrett-Connor E. A1C and diabetes diagnosis: The...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7665\n",
      "Documento: 5. The Diabetes Control and Complications Trial Research Group. The Effect of\n",
      "Intensive Treatment of Diabetes on the Development and Progression of Long-\n",
      "Term Complications in Insulin-Dependent Diabetes Mellitus. N Engl J Med\n",
      "1993;329\u0000977-986. \n",
      "6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood–glucose\n",
      "control with sulphonylureas or insulin compared with conventional treatment\n",
      "and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet.\n",
      "1998;352\u0000837–53....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7658\n",
      "Documento: ÍndiceMetas no tratamento do diabetes\n",
      "Classificação, diagnóstico e metas de tratamento(https://diretriz.diabetes.org.br/category/classificacao-diagnostico-e-metas-de-tratamento/) -\n",
      " Publicado em: 21 de julho de 2021 - Atualizado em: 22 de novembro de 2024...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7615\n",
      "Documento: diabetes. N Eng  J Med 2005;353\u00002643-53.\n",
      "9. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect\n",
      "of intensive treatment of diabetes on the development and progression of long-\n",
      "term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993\n",
      "Sep 30;329(14)\u0000977–86.\n",
      "10. Holman RR, Paul SK, Bethel AB, Matthews DR, Neil AW. 10-Year Follow-up of\n",
      "Intensive Glucose Control in Type 2 Diabetes. N Engl J Med 2008; 359\u00001577-1589.\n",
      "DOI: 10.1056/NEJMoa0806470....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7576\n",
      "Documento: IIb C\n",
      "Referências\n",
      "\u0000\u0000\u0000Bergman M, Manco M, Satman I, Chan J, Schmidt MI, Sesti G, et al.\n",
      "International Diabetes Federation Position Statement on the 1-hour post-load\n",
      "plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2\n",
      "diabetes. Diab Res Clin Pract. 2024 Mar;209\u0000111589.\n",
      "\u0000\u0000\u0000American Diabetes Association Professional Practice Committee. 2. Diagnosis\n",
      "and Classi\u0000cation of Diabetes: Standards of Care in Diabetes-2024. Diabetes...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7561\n",
      "Documento: within and between different diabetes types. Diabetologia. 2020\n",
      "Oct;63(10)\u00002040-8.\n",
      "\u0000\u0000\u0000\u0000Carr ALJ, Perry DJ, Lynam AL, Chamala S, Flaxman CS, Sharp SA, Ferrat LA,\n",
      "Jones AG, Beery ML, Jacobsen LM, Wasserfall CH, Campbell-Thompson ML,\n",
      "Kusmartseva I, Posgai A, Schatz DA, Atkinson MA, Brusko TM, Richardson SJ,\n",
      "Shields BM, Oram RA. Histological validation of a type 1 diabetes clinical\n",
      "diagnostic model for classi\u0000cation of diabetes. Diabet Med. 2020\n",
      "Dec;37(12)\u00002160-8....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7554\n",
      "Documento: 1998;352\u0000837–53.\n",
      "7. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al.\n",
      "Intensive blood glucose control and vascular outcomes in patients with type 2\n",
      "diabetes. N Engl J Med. 2008;358\u00002560–72.\n",
      "8. The  Diabetes Control and Complications Trial/Epidemiology of  Diabetes\n",
      "Interventions and Complications (DCCT/EDIC) Study Research Group.\n",
      "Intensive diabetes treatment and cardiovascular disease in patients with  type 1\n",
      "diabetes. N Eng  J Med 2005;353\u00002643-53....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7550\n",
      "Documento: 1994;308\u00001323–8.\n",
      "\u0000\u0000\u0000Zhang X, Gregg EW, Williamson DF, Barker LE, Thomas W, Bullard KM, et al.\n",
      "A1C level and future risk of diabetes: a systematic review. Diabetes Care. 2010\n",
      "Jul;33(7)\u00001665-73. doi: 10.2337/dc09-1939.\n",
      "\u0000\u0000\u0000Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, et al.\n",
      "Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing\n",
      "diabetes: diagnostic criteria and performance revisited. Diabetes Care.\n",
      "1997;20\u0000785–91....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7516\n",
      "Documento: 10.1016/j.cca.2012.12.026.\n",
      "\u0000\u0000\u0000\u0000Carson AP, Reynolds K, Fonseca VA, Muntner P. Comparison of A1C and\n",
      "fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes\n",
      "Care. 2010 Jan 1;33(1)\u000095–7. \n",
      "\u0000\u0000\u0000\u0000Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection\n",
      "of Type 2 diabetes: a systematic review. Diabet Med. 2007 Apr;24(4)\u0000333-43.\n",
      "doi: 10.1111/j.1464-5491.2007.02106.x.\n",
      "\u0000\u0000\u0000\u0000NCD Risk Factor Collaboration (NCD-RisC). Global variation in diabetes...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7514\n",
      "Documento: diabetes” tornou-se facilmente assimilado e difundido pelos pro\u0000ssionais de\n",
      "saúde. \n",
      "Quadro 1. Sinais e sintomas de hiperglicemia\n",
      "Sinais e sintomas TÍPICOS de hiperglicemia\n",
      "Resumo das recomendações\n",
      "(/diagnostico-\n",
      "de-diabetes-mellitus/?pdf=17554)\n",
      "...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7482\n",
      "Documento: glicemia no TTGO- 2h maior ou igual a 200 mg/dl. Se somente um\n",
      "exame estiver alterado, este deverá ser repetido para con\u0000rmação.\n",
      "ClasseI NívelB\n",
      "Sumário de evidências:\n",
      "O Report of the Expert Committee on the Diagnosis and Classi\u0000cation of\n",
      "Diabetes de 1997 de\u0000niu o ponto de corte da glicemia de jejum e da glicemia\n",
      "de duas horas após sobrecarga de glicose para diagnóstico de DM e de pré-\n",
      "diabetes com base em três coortes populacionais que avaliaram a associação...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7468\n",
      "Documento: Dianna J Magliano, Jayanthi Maniam, Trevor J Orchard, Priyanka Rai, Graham\n",
      "D Ogle. Global incidence, prevalence, and mortality of type 1 diabetes in 2021\n",
      "with projection to 2040\u0000 a modelling study. Lancet Diabetes Endocrinol 2022; 10\u0000\n",
      "741–60.\n",
      "\u0000\u0000\u0000\u0000Lynam A, McDonald T, Hill A, et al. Development and validation of multivariable\n",
      "clinical diagnostic models to identify type 1 diabetes requiring rapid insulin\n",
      "therapy in adults aged 18–50 years. BMJ Open\n",
      "2019;9\u0000e031586. doi\u000010.1136/bmjopen-2019-031586...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7451\n",
      "Documento: 2-diabetes.html\n",
      "16.  Le Roith D, Biessels GJ, Braithwaite S, Casanueva F, Draznin B, Halter J, et al. \n",
      "Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice\n",
      "Guideline. JCEM, Vol 104, Iss 5, May 2019, 1520–1574.\n",
      "17.  Gerstein HC, Miller ME, Ismail-Beigi F, Largay J, McDonald C, Lochnan HA,\n",
      "Booth GL; ACCORD Study Group. Effects of intensive glycaemic control on\n",
      "ischaemic heart disease: analysis of data from the randomised, controlled...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7389\n",
      "Documento: Introdução\n",
      "O diagnóstico de diabetes mellitus (DM) deve ser estabelecido pela identi\u0000cação\n",
      "de hiperglicemia. Para isto, podem ser usados a glicemia plasmática de jejum\n",
      "(GJ), o teste de tolerância à glicose por via oral (TTGO) e a hemoglobina glicada\n",
      "(HbA1c). O TTGO consiste em uma glicemia realizada após uma hora (TTGO-1h)\n",
      "ou duas horas (TTGO-2h) de uma sobrecarga de 75 gramas de glicose por via\n",
      "oral.\n",
      "Os sinais e sintomas sugestivos de hiperglicemia estão indicados no quadro 1....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7384\n",
      "Documento: and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric\n",
      "Diabetes Consortium Registries: comparing clinical characteristics and\n",
      "glycaemic control. Diabet Med. 2020;37(5)\u0000863–7.\n",
      "\u0000\u0000\u0000\u0000Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al.\n",
      "Characteristics of adolescents and youth with recent-onset type 2 diabetes:\n",
      "the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96(1)\u0000159–67....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7347\n",
      "Documento: ÍndiceClassificação do diabetes\n",
      "Classificação, diagnóstico e metas de tratamento(https://diretriz.diabetes.org.br/category/classificacao-diagnostico-e-metas-de-tratamento/) -\n",
      " Publicado em: 4 de maio de 2021 - Atualizado em: 3 de julho de 2024...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7334\n",
      "Documento: Study Group. BMJ. 1998 Aug 8;317(7155)\u0000371-5. doi: 10.1136/bmj.317.7155.371.\n",
      "\u0000\u0000\u0000\u0000Peddinti G, Bergman M, Tuomi T, Groop L. 1-hour post-OGTT glucose\n",
      "improves the early prediction of type 2 diabetes by clinical and metabolic\n",
      "markers. J Clin Endocrinol Metab 2019;104(4)\u00001131–40.\n",
      "\u0000\u0000\u0000\u0000Alyass A, Almgren P, Akerlund M, Dushoff J, Isomaa B, Nilsson P, et al.\n",
      "Modelling of OGTT curve identi\u0000es 1 h plasma glucose level as a strong\n",
      "predictor of incident type 2 diabetes: results from two prospective cohorts....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7328\n",
      "Documento: glicemia média estimada.\n",
      "Resumo das recomendações\n",
      "1,2\n",
      "3\n",
      "1\n",
      "2\n",
      "4\n",
      "\n",
      "(/metas-no-\n",
      "tratamento-do-diabetes/?pdf=3835)\n",
      "1Introdução\n",
      "2Recomendações\n",
      "3Tabela de Recomendações\n",
      "4Referências...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7258\n",
      "Documento: 14;129(2)\u0000188. \n",
      "\u0000\u0000\u0000\u0000Emerging Risk Factors Collaboration; Sarwar N, Gao P, Seshasai SR, Gobin R,\n",
      "Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose\n",
      "concentration, and risk of vascular disease: a collaborative meta-analysis of\n",
      "102 prospective studies. Lancet. 2010 Jun 26;375(9733)\u00002215-22.\n",
      "\u0000\u0000\u0000\u0000Gillett MJ. International Expert Committee report on the role of the A1c assay\n",
      "in the diagnosis of diabetes: Diabetes Care. 2009;32(7)\u00001327–34....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7235\n",
      "Documento: período. Pacientes com diagnóstico na vida adulta podem apresentar uma\n",
      "forma mais lentamente progressiva da doença, com evolução clínica mais\n",
      "branda.\n",
      "Quadro 1. Classi\u0000cação do diabetes\n",
      "Características / Complicações\n",
      "Diabetes tipo 1\n",
      "Imunomediado\n",
      "Idiopático\n",
      "Diabetes tipo 2\n",
      "Diabetes gestacional\n",
      "Outros tipos de Diabetes\n",
      "Defeitos monogênicos na função das células ß pancreáticas\n",
      "MODY (Mature Onset Diabetes of the Young)Diabetes neonatal transitório ou permanenteDiabetes mitocondrial...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7206\n",
      "Documento: Care. 2024 Jan 1;47(Suppl 1):S20-S42. doi: 10.2337/dc24-S002.\n",
      "\u0000\u0000\u0000Expert Committee on the Diagnosis and Classi\u0000cation of Diabetes Mellitus.\n",
      "Report of the Expert Committee on the Diagnosis and Classi\u0000cation of\n",
      "Diabetes Mellitus. Diabetes Care. 2003 Jan; 26(Suppl 1):S5-S20.\n",
      "\u0000\u0000\u0000Martínez-Vizcaíno V, Cavero-Redondo I, Álvarez-Bueno C, Rodríguez-Artalejo\n",
      "F. The accuracy of diagnostic methods for diabetic retinopathy: a systematic\n",
      "review and meta-analysis. PLoS One. 2016 Apr 28;11(4):e0154411. doi:...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7194\n",
      "Documento: Ismail-Beigi F, Grimm RH Jr, Probst\u0000eld JL, Simons-Morton DG, Friedewald WT.\n",
      "Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun\n",
      "12;358(24)\u00002545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6. PMID:\n",
      "18539917; PMCID: PMC4551392.\n",
      "13.  Reaven PD, Emanuele NV, Wiitala WL, Bahn GD, Reda DJ, McCarren M,\n",
      "Duckworth WC, Hayward RA; VADT Investigators. Intensive Glucose Control in\n",
      "Patients with Type 2 Diabetes – 15-Year Follow-up. N Engl J Med. 2019 Jun...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7182\n",
      "Documento: DM para DM 2 ou DM monogênico.\n",
      "Nota importante 2\u0000 Início da Insulinoterapia\n",
      "Na suspeita de DM1 o tratamento com insulina deve ser iniciado\n",
      "imediatamente, independentemente da con\u0000rmação laboratorial do\n",
      "diagnóstico.\n",
      "Nota importante 3\u0000 Peptídeo C\n",
      "A dosagem do peptídeo C deve ser efetuada com o diabetes razoavelmente\n",
      "controlado, na ausência de hipoglicemias (glicemias > 100 mg/dL, de\n",
      "preferência) ou glicemias acima de 200 mg/dL. Deve ser realizada, de...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7180\n",
      "Documento: crônicas.  A Sociedade Brasileira de Diabetes (SBD) recomenda a classi\u0000cação\n",
      "baseada na etiopatogenia do diabetes, que compreende o diabetes tipo 1 (DM1),\n",
      "o diabetes tipo 2 (DM2), o diabetes gestacional (DMG) e os outros tipos de\n",
      "diabetes (Quadro 1). Outras classi\u0000cações têm sido propostas, incluindo\n",
      "classi\u0000cação em  subtipos de DM levando em conta características clínicas\n",
      "como o momento do início do diabetes, a história familiar, a função residual das...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7180\n",
      "Documento: Kingdom Prospective Diabetes Study) mostraram que manter HbA1c abaixo de\n",
      "7% reduz as complicações microvasculares no diabetes tipo 1 e 2. \n",
      "No DCCT, 1441 pacientes com diabetes em uso de insulina foram\n",
      "randomizados para grupo de tratamento intensivo ou convencional e seguido\n",
      "por uma média de 6,5 anos. O tratamento intensivo foi capaz de reduzir o\n",
      "5 6...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7158\n",
      "Documento: Challenges. Diabetes Care. 2021 Nov;44(11)\u00002449-2456. doi: 10.2337/dc21-0770.\n",
      "\u0000\u0000\u0000\u0000Fang M, Jeon Y, Echouffo-Tcheugui JB, Selvin E. Prevalence and Management of\n",
      "Obesity in U.S. Adults With Type 1 Diabetes. Ann Intern Med. 2023\n",
      "Mar;176(3)\u0000427-429. doi: 10.7326/M22-3078.\n",
      "\u0000\u0000\u0000\u0000Gabriel A Gregory*, Thomas I G Robinson*, Sarah E Linklater, Fei Wang,\n",
      "Stephen Colagiuri, Carine de Beaufort, Kim C Donaghue, International Diabetes\n",
      "Federation Diabetes Atlas Type 1 Diabetes in Adults Special Interest Group † ,...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7147\n",
      "Documento: Diagnóstico de diabetes mellitus\n",
      "Classificação, diagnóstico e metas de tratamento(https://diretriz.diabetes.org.br/category/classificacao-diagnostico-e-metas-de-tratamento/) -\n",
      " Publicado em: 5 de julho de 2024- Atualizado em: 19 de fevereiro de 2025...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7137\n",
      "Documento: Lahti K, Forsén T, Tuomi T, Rosengren AH, Groop L. Novel subgroups of adult-\n",
      "onset diabetes and their association with outcomes: a data-driven cluster\n",
      "analysis of six variables.  Lancet Diabetes Endocrinol. 2018 May;6(5)\u0000361-9.\n",
      "\u0000\u0000\u0000Classi\u0000cation of diabetes mellitus. Geneva: World Health Organization; 2019.\n",
      "Licence: CC BY-NC-SA 3.0 IGO.\n",
      "\u0000\u0000\u0000Shields BM, et al. BMJ Open. 2015;5\u0000e009088. doi\u000010.1136/bmjopen-2015-\n",
      "009088.\n",
      "\u0000\u0000\u0000NICE Guideline www.nice.org.uk/guidance/ng18....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7135\n",
      "Documento: autoantibodies. Pediatr Diabetes 2012;13\u0000308–313.\n",
      "\u0000\u0000\u0000\u0000Duca LM, Wang B, Rewers M, Rewers A. Diabetic ketoacidosis at diagnosis of\n",
      "type 1 diabetes predicts poor long-term glycemic control. Diabetes Care\n",
      "2017;40\u00001249–1255.\n",
      "\u0000\u0000\u0000\u0000Sims EK, Besser REJ, Dayan C, Geno Rasmussen C, Greenbaum C, Grif\u0000n KJ,\n",
      "et al; NIDDK Type 1 Diabetes TrialNet Study Group. Screening for type 1\n",
      "diabetes in the general population: A status report and perspective. Diabetes.\n",
      "2022 Apr 1;71(4)\u0000610-623. doi: 10.2337/dbi20-0054....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7134\n",
      "Documento: \u0000\u0000\u0000\u0000Greenbaum CJ, Harrison LC, Immunology of Diabetes Society. Guidelines for\n",
      "intervention trials in subjects with newly diagnosed type 1 diabetes. Diabetes.\n",
      "2003;52\u00001059–65.\n",
      "\u0000\u0000\u0000\u0000 Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al.\n",
      "Characteristics of adolescents and youth with recent-onset type 2 diabetes:\n",
      "the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96(1)\u0000159-67.\n",
      "\u0000\u0000\u0000\u0000Petersmann A.  De\u0000nition, classi\u0000cation and diagnosis of diabetes mellitus....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7126\n",
      "Documento: development of Type2 Diabetes-11 years observational study from South\n",
      "India. Diabetes Metab Syndr 2019;13(4)\u00002733–7.\n",
      "\u0000\u0000\u0000\u0000Ha J, Chung ST, Bogardus C, Jagannathan R, Bergman M, Sherman AS. One-\n",
      "hour glucose is an earlier marker of dysglycemia than two-hour glucose.\n",
      "Diabetes Res Clin Pract. 2023 Sep;203\u0000110839. doi:\n",
      "10.1016/j.diabres.2023.110839.\n",
      "\u0000\u0000\u0000\u0000Alyass A, Almgren P, Akerlund M, Dushoff J, Isomaa B, Nilsson P, et al.\n",
      "Modelling of OGTT curve identi\u0000es 1 h plasma glucose level as a strong...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7107\n",
      "Documento: 6;380(23)\u00002215-2224. doi: 10.1056/NEJMoa1806802. PMID: 31167051; PMCID:\n",
      "PMC6706253.\n",
      "14. Turnbull F,M  Abraira C ,  Anderson R J, et al: Intensive glucose control and\n",
      "macrovascular outcomes in type 2 diabetes(https://pubmed.ncbi.nlm.nih.gov/?\n",
      "term=Turnbull+FM&cauthor_id=19655124)Diabetologia 2009 Nov; 52(11)\u00002288-\n",
      "98. \n",
      "15. INTERNATIONAL DIABETES FEDERATION: Managing Older People With\n",
      "Type 2 Diabetes Global Guideline. Disponível em https://www.idf.org/e-...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7094\n",
      "Documento: May;33(5)\u0000983-90. \n",
      "19.  Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose\n",
      "on cardiovascular outcomes and death in patients with diabetes mellitus: a\n",
      "meta-analysis of randomised controlled trials. Lancet. 2009;373\u00001765–1772.\n",
      "20.  Grif\u0000th KN, Prentice JC, Mohr DC, Conlin PR. Predicting 5- and 10-Year\n",
      "Mortality Risk in Older Adults With Diabetes. Diabetes Care. 2020 Jun\n",
      "19;43(8)\u00001724–31.\n",
      "21.  Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7090\n",
      "Documento: acesso a análogos de insulina ou sistemas avançados de liberação de\n",
      "insulina, impossibilidade de monitorização glicêmica regular ou\n",
      "monitorização contínua de glicose e incapacidade de reportar\n",
      "sintomas de hipoglicemia (Quadro 2).\n",
      "Classe IIa Nível C\n",
      "34\n",
      "19,20,21\n",
      "23\n",
      "24\n",
      "25...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7088\n",
      "Documento: value of classi\u0000cation schemes for ketosis-prone diabetes. Diabetes Care.\n",
      "2006;29(12)\u00002575-9. https://doi.org/10. 2337/dc06-0749\n",
      "\u0000\u0000\u0000\u0000Hart PA, Bellin MD, Andersen DK, Bradley D, Cruz-Monserrate Z, Forsmark\n",
      "CE, Goodarzi MO, Habtezion A, Korc M, Kudva YC, Pandol SJ, Yadav D, Chari\n",
      "ST; Consortium for the Study of Chronic Pancreatitis, Diabetes, and\n",
      "Pancreatic Cancer(CPDPC). Type 3c (pancreatogenic) diabetes mellitus\n",
      "secondary to chronic pancreatitis and pancreatic cancer. Lancet...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7080\n",
      "Documento: Jasinskiene E, Mockeviciene G, Schwitzgebel VM. Systematic genetic study of\n",
      "youth with diabetes in a single country reveals the prevalence of diabetes\n",
      "subtypes, novel candidate genes, and response to precision therapy. Diabetes.\n",
      "2020 May;69(5)\u00001065-71.\n",
      "\u0000\u0000\u0000\u0000Shields BM, Shepherd M, Hudson M, et al; UNITED study team. Population-\n",
      "based assessment of a biomarker-based screening pathway to aid diagnosis of\n",
      "monogenic diabetes in young-onset patients. Diabetes Care 2017;40(8)\u00001017-...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7078\n",
      "Documento: I C\n",
      "R4 – É RECOMENDADO que pessoas adultas com diabetes eanticorpos positivos, as quais não necessitam de insulina por pelomenos seis meses após o diagnóstico, sejam classi\u0000cadas como tendodiabetes autoimune latente do adulto (Latent Autoimmune Diabetesin Adults (LADA).\n",
      "I C...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7069\n",
      "Documento: comparado ao grupo convencional. A redução de risco em qualquer desfecho\n",
      "composto relacionado ao diabetes foi de 25% (IC 95% 7-40, p=0;0099) em\n",
      "eventos microvasculares.\n",
      "Resultados similares foram vistos no estudo ADVANCE (Action in Diabetes\n",
      "and Vascular Disease: Preterax and Diamicron modi\u0000ed release controlled\n",
      "evaluation) o qual randomizou 11.140 indivíduos com DM2 para serem\n",
      "submetidos a tratamento padrão ou tratamento intensivo. Após seguimento...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7062\n",
      "Documento: incorporation into an autoantibody risk score in relatives of type 1 diabetic\n",
      "patients. Diabetes Care. 2013 Sep;36(9)\u00002615–20. \n",
      "...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7061\n",
      "Documento: al. Management of hyperglycemia in type 2 diabetes: a patient-centered\n",
      "approach: position statement of the American Diabetes Association (ADA) and\n",
      "the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012\n",
      "Jun;35(6)\u00001364–79.\n",
      "22.  American Diabetes Association. 12. Older Adults: Standards of Medical Care\n",
      "in Diabetes-2021. Diabetes Care. 2021 Jan;44(Suppl 1):S168–79.     \n",
      "23. Palta P, Huang E, Kalyani R, Golden S, Yeh H-S. Hemoglobin A1c and...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7058\n",
      "Documento: (https://diretriz.diabetes.org.br/)\n",
      "InicialÍndice EditorialComitê CentralAutoriaRevistas InternacionaisEdições AnterioresFale Conosco...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7058\n",
      "Documento: (https://diretriz.diabetes.org.br/)\n",
      "InicialÍndice EditorialComitê CentralAutoriaRevistas InternacionaisEdições AnterioresFale Conosco...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7039\n",
      "Documento: Engl J Med. 1984;311\u0000149–52. \n",
      "\u0000\u0000\u0000\u0000Couper JJ, Haller MJ, Greenbaum CJ, Ziegler AG, Wherrett DK, Knip M, Craig\n",
      "ME. ISPAD Clinical Practice Consensus Guidelines 2018\u0000 Stages of type 1\n",
      "diabetes in children and adolescents. Pediatr Diabetes. 2018 Oct;19 Suppl\n",
      "27\u000020–27. \n",
      "\u0000\u0000\u0000\u0000Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, et al.\n",
      "Seroconversion to multiple islet autoantibodies and risk of progression to\n",
      "diabetes in children. JAMA. 2013 Jun 19;309(23)\u00002473....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7036\n",
      "Documento: Diabetologia. 2015 Jan;58(1)\u000087-97. doi: 10.1007/s00125-014-3390-x.\n",
      "\u0000\u0000\u0000\u0000Manco M, Panunzi S, Macfarlane DP, Golay A, Melander O, Konrad T, et al.\n",
      "One-hour plasma glucose identi\u0000es insulin resistance and β -cell dysfunction\n",
      "in individuals with Normal glucose tolerance: cross-sectional data from the\n",
      "relationship between insulin sensitivity and cardiovascular risk (RISC) study.\n",
      "Diabetes Care 2010;33(9)\u00002090–7.\n",
      "\u0000\u0000\u0000\u0000Manco M, Mari A, Petrie J, Mingrone G, Balkau B. One hour post-load plasma...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.7006\n",
      "Documento: entre os níveis glicêmicos e o surgimento de retinopatia diabética.³⁻ ⁹ \n",
      "Um estudo de coorte demonstrou uma relação contínua entre níveis\n",
      "glicêmicos e desenvolvimento de retinopatia diabética. Entretanto, há um\n",
      "limiar que divide os indivíduos em maior risco de complicações relacionadas\n",
      "ao DM daqueles em menor risco, o que é utilizado para determinar o ponto de\n",
      "corte para diagnóstico de DM.¹ ⁰   Este limiar não é uniforme entre os estudos....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6994\n",
      "Documento: 2019;9\u0000e031586. doi\u000010.1136/bmjopen-2019-031586\n",
      "\u0000\u0000\u0000\u0000Tatovic D, Jones AG, Evans C, Long AE, Gillespie K, Besser REJ, Leslie RD, Dayan\n",
      "CM; Type 1 diabetes UK Immunotherapy Consortium. Diagnosing Type 1\n",
      "diabetes in adults: Guidance from the UK T1D Immunotherapy consortium.\n",
      "Diabet Med. 2022 Jul;39(7):e14862. doi: 10.1111/dme.\n",
      "Cite este artigo\n",
      "Rodacki M, Teles M, Gabbay M, Montenegro R, Bertoluci M, Rodrigo\n",
      "Lamounier. Classi\u0000cação do diabetes. Diretriz O\u0000cial da Sociedade Brasileira...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6982\n",
      "Documento: Diabetes tipo 2 propenso à cetose:\n",
      "R9 – Para pessoas com cetoacidose ao diagnóstico de DM, com\n",
      "evolução subsequente para baixa ou nenhuma necessidade de\n",
      "insulina, É RECOMENDADO a dosagem do peptídeo C e de\n",
      "autoanticorpos associados ao DM, especialmente na presença de\n",
      "obesidade e sinais clínicos de resistência à insulina.\n",
      "Classe I Nível B\n",
      "Sumário de evidências:\n",
      "Cetoacidose diabética pode ocorrer não apenas nos casos de DM1, mas\n",
      "também em DM2, especialmente em populações multiétnicas. Em alguns...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6960\n",
      "Documento: predictor of incident type 2 diabetes: results from two prospective cohorts.\n",
      "Diabetologia 2015;58(1)\u000087–97.\n",
      "\u0000\u0000\u0000\u0000Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, et\n",
      "al. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2\n",
      "Diabetes Than Impaired Fasting Glucose. J Clin Endocrinol Metab. 2015\n",
      "Oct;100(10)\u00003744-51. doi: 10.1210/jc.2015-2573.\n",
      "\u0000\u0000\u0000\u0000Chung S, Azar KM, Baek M, Lauderdale DS, Palaniappan LP. Reconsidering the...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6955\n",
      "Documento: I C\n",
      "R5 – É RECOMENDADO suspeitar de diabetes monogênico empacientes com hiperglicemia de início antes dos 25 anos de idade,com história familiar de diabetes surgindo antes de 25 anos em duasou três gerações. Os autoanticorpos devem ser negativos e opeptídeo C detectável acima de 0,6 ng/ml após cinco anos dodiagnóstico de DM.\n",
      "I B...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6951\n",
      "Documento: (https://diretriz.diabetes.org.br/)\n",
      "InicialÍndice EditorialComitê CentralAutoriaRevistas InternacionaisEdições AnterioresFale Conosco\n",
      "...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6949\n",
      "Documento: population-based study. Diabetes Care. 1997;20(2)\u0000198-201.\n",
      "\u0000\u0000\u0000\u0000Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the\n",
      "care of patients with diabetes. Diabet Med. 2013 Jul;30(7)\u0000803-17. \n",
      "\u0000\u0000\u0000\u0000Foteinopoulou E, Clarke CAL, Pattenden RJ, Ritchie SA, McMurray EM,\n",
      "Reynolds RM, Arunagirinathan G, Gibb FW, McKnight JA, Strachan MWJ.\n",
      "Impact of routine clinic measurement of serum C-peptide in people with a\n",
      "clinician-diagnosis of type 1 diabetes. Diabet Med. 2020 Nov 1;:e14449....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6910\n",
      "Documento: \u0000\u0000\u0000\u0000Ahuja V, Aronen P, Pramodkumar TA, Looker H, Chetrit A, Bloigu AH, et al.\n",
      "Accuracy of 1-hour plasma glucose during the Oral glucose tolerance test in\n",
      "diagnosis of type 2 diabetes in adults: a meta-analysis. Diabetes Care\n",
      "2021;44(4): 1062–9.\n",
      "...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6894\n",
      "Documento: 29. Klonoff DC. ADAG study group data links A1C levels with empirically\n",
      "measured blood glucose values – new treatment guidelines will now be needed.\n",
      "J Diabetes Sci Technol. 2014;8(3)\u0000439-443. \n",
      "30. DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, et al. ISPAD\n",
      "Clinical Practice Consensus Guidelines 2018\u0000 Glycemic control targets and\n",
      "glucose monitoring for children, adolescents, and young adults with diabetes.\n",
      "Pediatr Diabetes 2018;19(Suppl. 27)\u0000105–14....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6887\n",
      "Documento: Dec;37(12)\u00002160-8.\n",
      "\u0000\u0000\u0000\u0000Lynam A, McDonald T, Hill A, Dennis J, Oram R, Pearson E, Weedon M,\n",
      "Hattersley A, Owen K, Shields B, Jones A. Development and validation of\n",
      "multivariable clinical diagnostic models to identify type 1 diabetes requiring\n",
      "rapid insulin therapy in adults aged 18-50 years. BMJ Open. 2019 Sep\n",
      "26;9(9):e031586.\n",
      "\u0000\u0000\u0000\u0000Garnier L, Marchand L, Benoit M, Nicolino M, Bendelac N, Wright C, Moulin P,\n",
      "Lombard C, Thivolet C, Fabien N. Screening of ZnT8 autoantibodies in the...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6876\n",
      "Documento: Oct\u0000120\u0000221–8.\n",
      "\u0000\u0000\u0000\u0000Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al.\n",
      "Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.\n",
      "N Engl J Med. 2010;362(9)\u0000800v11.\n",
      "\u0000\u0000\u0000\u0000Kato M, Noda M, Suga H, Matsumoto M, Kanazawa Y. Fasting plasma glucose\n",
      "and incidence of diabetes — implication for the threshold for impaired fasting\n",
      "glucose: results from the population-based Omiya MA cohort study. J\n",
      "Atheroscler Thromb. 2009;16(6)\u0000857-61. doi: 10.5551/jat.1792....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6864\n",
      "Documento: “hiperglicemia intermediária”¹, composta pela “glicemia de jejum alterada”, nos\n",
      "casos em que a disglicemia leve ocorre em jejum e pela “intolerância à glicose”,\n",
      "na situação em que há hiperglicemia leve após TTGO, sem preencher critérios\n",
      "para DM. A American Diabetes Association (ADA) e a Sociedade Brasileira de\n",
      "Diabetes (SBD) utilizam a nomenclatura “pré-diabetes” para estes indivíduos.²\n",
      "Embora nem todos os indivíduos desse grupo evoluam para DM, o termo “pré-...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6853\n",
      "Documento: 1997;20\u0000785–91.\n",
      "\u0000\u0000\u0000Colagiuri S, Lee CMY, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K, et al.\n",
      "Glycemic thresholds for diabetes-speci\u0000c retinopathy: implications for\n",
      "diagnostic criteria for diabetes. Diabetes Care. 2011;34(1)\u0000145–50.\n",
      "...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6852\n",
      "Documento: realizar o TTGO-1h para complementar a investigação de DM e pré-\n",
      "diabetes. \n",
      "ClasseI NívelC\n",
      "Sumário de evidências:\n",
      "Pessoas sem critérios para DM e pré-diabetes, mas com alteração no TTGO-\n",
      "1h, representam um estágio intermediário de disfunção metabólica. No estudo\n",
      "RISC, os indivíduos com GJ e TTGO-2h normais, que apresentavam valores\n",
      "mais elevados de TTGO-1h, apresentaram maior resistência à insulina (RI) e\n",
      "progrediram mais para intolerância à glicose (determinada pelo TTGO-2h) em...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6852\n",
      "Documento: Classe I Nível C\n",
      "Sumário de evidências:\n",
      "Diabetes associado a outras doenças pancreáticas, como in\u0000amações (mais\n",
      "frequentemente causadas por etilismo ou litíase biliar), neoplasias,\n",
      "hemocromatose e cirurgias pancreáticas prévias, constituem 0,5% a 9,2% dos\n",
      "casos de DM.  Comumente são erroneamente classi\u0000cados como DM2.\n",
      "Não há critérios universalmente aceitos para o diagnóstico de diabetes\n",
      "secundário a doenças pancreáticas exócrinas, também conhecido como\n",
      "diabetes 3c....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6839\n",
      "Documento: DOI: 10.1056/NEJMoa0806470.\n",
      "11.  Heller SR; ADVANCE Collaborative Group. A summary of the ADVANCE Trial.\n",
      "Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S357-61. doi: 10.2337/dc09-S339.\n",
      "PMID: 19875581; PMCID: PMC2811451.VADT – N Engl J Med 2009; 360\u0000129-139.\n",
      "DOI: 10.1056/NEJMoa0808431.\n",
      "12. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC,\n",
      "Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S,...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6809\n",
      "Documento: Jun;30(6)\u0000671–5.\n",
      "\u0000\u0000\u0000\u0000Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict\n",
      "type 2 diabetes risk. Diabetes Care 2003;26\u0000725-31.\n",
      "\u0000\u0000\u0000\u0000Barim EM, McLellan KCP, Ribeiro RS, Carvalho JAM, Lindstrom J, Tuomilehto J,\n",
      "et al. Tradução e adaptação transcultural para o português brasileiro do\n",
      "Escore Finlandês de Risco de Diabetes (FINDRISC) e avaliação da\n",
      "con\u0000abilidade. Rev Bras Epidemiol 2020;23\u0000E200060. doi: 10.1590/1980-\n",
      "549720200060....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6780\n",
      "Documento: autoanticorpos. Em jovens com DM 2, os anticorpos não estão presentes e\n",
      "os níveis de peptídeo C são normais ou elevados.\n",
      "Figura 1. Fluxograma decisório para diagnóstico diferencial de diversos tipos de\n",
      "diabetes, em caso de dúvida diagnóstica.\n",
      "(https://diretriz.diabetes.org.br/wp-content/uploads/2021/05/0001-\n",
      "scaled.jpg)\n",
      "Diabetes LADA:\n",
      "R4 – É RECOMENDADO que pessoas adultas com diabetes e\n",
      "anticorpos positivos, as quais não necessitam de insulina por pelo...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6766\n",
      "Documento: \u0000\u0000\u0000\u0000Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, et al;\n",
      "Type 1 Diabetes TrialNet Study Group. An anti-CD3 antibody, teplizumab, in\n",
      "relatives at risk for type 1 diabetes. N Engl J Med. 2019;381\u000060–613.\n",
      "\u0000\u0000\u0000\u0000Winkler C, Schober E, Ziegler AG, Holl RW. Markedly reduced rate of diabetic\n",
      "ketoacidosis at onset of type 1 diabetes in relatives screened for islet\n",
      "autoantibodies. Pediatr Diabetes 2012;13\u0000308–313....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6764\n",
      "Documento: 14;12\u000060. doi: 10.1186/s13098-020-00570-y.\n",
      "\u0000\u0000\u0000\u0000Suh S, Park MK. Glucocorticoid-induced diabetes mellitus: an important but\n",
      "overlooked problem. Endocrinol Metab. 2017;32(2)\u0000180. \n",
      "\u0000\u0000\u0000\u0000Imatoh T, Sai K, Hori K, Segawa K, Kawakami J, Kimura M, et al. Development\n",
      "of a novel algorithm for detecting glucocorticoid-induced diabetes mellitus\n",
      "using a medical information database. J Clin Pharm Ther. 2017 Apr;42(2)\u0000215–\n",
      "20. \n",
      "\u0000\u0000\u0000\u0000Holt RIG. Association between antipsychotic medication use and diabetes....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6752\n",
      "Documento: 10.1111/dme.14181.\n",
      "\u0000\u0000\u0000\u0000Selvin E, Wang D, Matsushita K, Grams ME, Coresh J. Prognostic implications\n",
      "of single-sample con\u0000rmatory testing for undiagnosed diabetes: a\n",
      "prospective cohort study. Ann Intern Med. 2018 Aug 7;169(3)\u0000156. \n",
      "\u0000\u0000\u0000\u0000Rushforth NB, Bennett PH, Steinberg AG, Miller M. Comparison of the value of\n",
      "the two- and one-hour glucose levels of the oral GTT in the diagnosis of\n",
      "diabetes in Pima Indians. Diabetes. 1975 Jun;24(6)\u0000538-46. doi:\n",
      "10.2337/diab.24.6.538....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6745\n",
      "Documento: risk for future type 2 diabetes. Diabetes Care. 2008 Aug;31(8)\u00001650-5. doi:\n",
      "10.2337/dc08-0225.\n",
      "\u0000\u0000\u0000\u0000Abdul-Ghani MA, Abdul-Ghani T, Stern MP, Karavic J, Tuomi T, Bo I, et al.\n",
      "Two-step approach for the prediction of future type 2 diabetes risk. Diabetes\n",
      "Care 2011;34(9)\u00002108–12.\n",
      "\u0000\u0000\u0000\u0000Kumpatla S, Parveen R, Stanson S, Viswanathan V. Elevated one hour with\n",
      "normal fasting and 2 h plasma glucose helps to identify those at risk for\n",
      "...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6741\n",
      "Documento: diferenciação de DM1 e DM2. Embora composta por apenas 11 estudos e com\n",
      "considerável heterogeneidade, demonstrou-se que a idade no diagnóstico, o\n",
      "uso de insulina, o tempo para início de insulinoterapia e o índice de massa\n",
      "corporal foram preditores independentes e bons para diferenciação entre os\n",
      "dois tipos principais de diabetes, em especial a combinação de idade ao\n",
      "diagnóstico e tempo para início de insulina. \n",
      "O Royal College of General Practitioners National Health Service Diabetes...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6706\n",
      "Documento: (12-14 pontos); alto (15-20 pontos) e muito alto (mais de 20 pontos).⁴⁵ ,⁴⁶  O\n",
      "escore FINDRISC está pormenorizado na Figura 1, e pode ser encontrado no\n",
      "site da SBD através do link https://diabetes.org.br/calculadoras/\u0000ndrisc\n",
      "(https://diabetes.org.br/calculadoras/\u0000ndrisc).\n",
      "O rastreamento de DM2 permite detecção precoce da doença, o que pode\n",
      "reduzir o risco de suas complicações crônicas. Além disso, identi\u0000ca pessoas\n",
      "com maior propensão para desenvolvimento de DM, que poderão se...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6702\n",
      "Documento: • Cetoacidose diabética ao diagnóstico em adultos, evoluindo subsequentemente combaixas doses de insulina, especialmente em associação com obesidade.\n",
      "R2 – Em casos de suspeita clínica de DM1 em adultos,É\n",
      "RECOMENDADO a solicitação de autoanticorpos. O resultado\n",
      "positivo con\u0000rma o diagnóstico de DM1.\n",
      "Classe I Nível B\n",
      "Sumário de evidências:\n",
      "A diferenciação fenotípica entre DM1 e DM2 pode ser desa\u0000adora em alguns\n",
      "casos, tanto em adultos como em crianças....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6693\n",
      "Documento: pelo National Glycohemoglobin Standardization Program (NGSP),\n",
      "estabelecida para a aplicabilidade no estudo Diabetes Control and\n",
      "Complications Trial(DCCT).² ⁵ \n",
      "R2. Na presença de sintomas típicos de hiperglicemia, É\n",
      "RECOMENDADO que o diagnóstico seja estabelecido quando houver\n",
      "glicemia plasmática ao acaso maior ou igual a 200 mg/dl.\n",
      "ClasseI NívelC\n",
      "Sumário de evidências:\n",
      "Este painel considera que, com o intuito de não postergar o início de...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6690\n",
      "Documento: Pediatr Diabetes 2018;19(Suppl. 27)\u0000105–14.\n",
      "31.  Vigersky RA, McMahon C. The Relationship of Hemoglobin A1C to Time-in-\n",
      "Range in Patients with Diabetes. Diabetes Technol Ther. 2019; 21(2)\u000081–5.\n",
      "32. Monnier L, Colette C, Wojtusciszyn A, et al. Toward de\u0000ning the threshold\n",
      "between low and high glucose variability in diabetes. Diabetes Care\n",
      "2017;40\u0000832–838\n",
      "33. Danne T. International Consensus on Use of Continuous Glucose Monitoring\n",
      "Diabetes Care 2017;40\u00001631–1640....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6685\n",
      "Documento: R5 – É RECOMENDADO utilizar como ponto de corte de glicemiano TTGO-1h ≥  209 mg/dl para diagnóstico de DM2 e ≥  155 mg/dlpara detecção de pré-diabetes. I C\n",
      "R6 – É RECOMENDADO o rastreamento de DM2 para todos osindivíduos com idade ≥  35 anos e para os demais adultos comsobrepeso/obesidade que tenham pelo menos um fator de riscoadicional para DM2 (Quadro 2) e/ou que apresentem FINDRISCalto/muito alto.\n",
      "I B...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6683\n",
      "Documento: possivelmente por menor sensibilidade à insulina e disfunção de células\n",
      "beta.³ ⁹ \n",
      "RASTREAMENTO PARA DIABETES MELLITUS TIPO 2 (DM2)\n",
      "R6. É RECOMENDADO o rastreamento de DM2 para todos os\n",
      "indivíduos com idade maior ou igual a 35 anos e para adultos com\n",
      "sobrepeso ou obesidade, que tenham pelo menos um fator de risco\n",
      "adicional para DM2 (Quadro 2), e ou que apresentem FINDRISC alto\n",
      "ou muito alto.\n",
      "ClasseI NívelB\n",
      "Sumário de evidências:...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6677\n",
      "Documento: casos, ocorre cetoacidose diabética ao diagnóstico, geralmente sem fator\n",
      "precipitante evidente, com anticorpos negativos (evidenciando ausência de\n",
      "autoimunidade) e peptídeo C detectável ou até mesmo dentro da\n",
      "normalidade, com evolução subsequente compatível com DM2, sendo\n",
      "geralmente possível a retirada de insulina e tratamento com outros agentes\n",
      "antidiabéticos.  Esse quadro é denominado DM2 propenso a cetose. \n",
      "Balasubramanyam et al. avaliaram a acurácia e o valor preditivo da utilização...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6674\n",
      "Documento: hipoglicemias graves e frequentes.\n",
      "ClasseI NívelB\n",
      "Sumário de evidências:\n",
      "Em indivíduos com DM tipo 1, a adoção do controle intensivo da glicemia,\n",
      "objetivando HbA1c abaixo de 7% nos primeiros 6 anos de diabetes pode\n",
      "promover redução de 57% na ocorrência de infarto não fatal do miocárdio\n",
      "(IAM) não fatal, acidente vascular cerebral (AVC) e morte por doença\n",
      "cardiovascular (DCV) no seguimento de longo prazo (9 anos), conforme\n",
      "observado no estudo DCCT/EDIC.\n",
      "5\n",
      "6\n",
      "7,\n",
      "7\n",
      "8,9...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6627\n",
      "Documento: 3), ISBN: 978-85-5722-906-8.\n",
      "Copiar Citação\n",
      "Diretriz da Sociedade Brasileira de Diabetes – 2024Aprovado pelo Comitê Central (https://diretriz.diabetes.org.br/comite-central/) – DOI: 10.29327/5412848 (https://doi.org/10.29327/5412848) / ISBN: 978-65-272-0704-7Todos os direitos reservados – Política de Privacidade (https://diabetes.org.br/politica-de-privacidade/)\n",
      "(https://www.conectandopessoas.com.br/)...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6606\n",
      "Documento: muito comprometidos de acordo com tabela 1) ou pessoas com presença de\n",
      "múltiplas comorbidades e complicações do DM que impliquem em maior risco\n",
      "de hipoglicemia severa.\n",
      "Recomendações\n",
      "R1\u0000 É RECOMENDADA a meta de HbA1c < 7,0% para todos os\n",
      "indivíduos com diabetes, para prevenção de complicações\n",
      "microvasculares, desde que não incorra em hipoglicemias graves e\n",
      "frequentes.\n",
      "Classe I Nível A\n",
      "Sumário de evidências:\n",
      "O DCCT (Diabetes Control and Complications Trial) e o UKPDS (United...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6605\n",
      "Documento: \u0000\u0000\u0000\u0000Johnson SL, Tabaei BP, Herman WH. The ef\u0000cacy and cost of alternative\n",
      "strategies for systematic screening for type 2 diabetes in the U.S. population\n",
      "45-74 years of age. Diabetes Care. 2005 Feb 1;28(2)\u0000307–11. \n",
      "...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6602\n",
      "Documento: \u0000\u0000\u0000NICE Guideline www.nice.org.uk/guidance/ng18.\n",
      "\u0000\u0000\u0000Yeow TP, Aun ES, Hor CP, Lim SL, Khaw CH, Aziz NA. Challenges in the\n",
      "classi\u0000cation and management of Asian youth-onset diabetes mellitus-\n",
      "lessons learned from a single centre study. PLoS One. 2019 Jan\n",
      "25;14(1):e0211210. \n",
      "\u0000\u0000\u0000Ke et al. Development and validation of algorithms to classify type 1 and 2\n",
      "diabetes according to age at diagnosis using electronic health records. BMC\n",
      "Medical Research Methodology 2020;20\u000035...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6600\n",
      "Documento: 978-65-272-0704-7.\n",
      "Copiar Citação\n",
      "Diretriz da Sociedade Brasileira de Diabetes – 2024Aprovado pelo Comitê Central (https://diretriz.diabetes.org.br/comite-central/) – DOI: 10.29327/5412848 (https://doi.org/10.29327/5412848) / ISBN: 978-65-272-0704-7Todos os direitos reservados – Política de Privacidade (https://diabetes.org.br/politica-de-privacidade/)\n",
      "(https://www.conectandopessoas.com.br/)\n",
      "...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6593\n",
      "Documento: 26;16(19)\u00003598. \n",
      "\u0000\u0000\u0000\u0000Cavagnolli G, Comerlato J, Comerlato C, Renz PB, Gross JL, Camargo JL. HbA1c\n",
      "measurement for the diagnosis of diabetes: is it enough?: HbA1c test and\n",
      "diabetes diagnosis. Diabet Med. 2011 Jan;28(1)\u000031–5. \n",
      "\u0000\u0000\u0000\u0000Kaur G, Lakshmi PVM, Rastogi A, Bhansali A, Jain S, Teerawattananon Y, et al.\n",
      "Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic\n",
      "review and meta-analysis. PLoS One. 2020 Nov 20;15(11):e0242415. doi:\n",
      "10.1371/journal.pone.0242415....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6582\n",
      "Documento: Exp Clin Endocrinol Diabetes. 2019;127(Suppl 1):S1–S7.\n",
      "\u0000\u0000\u0000\u0000Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD.\n",
      "Management of latent autoimmune diabetes in adults: a consensus statement\n",
      "from an International Expert Panel. Diabetes. 2020 Oct;69(10)\u00002037-47.\n",
      "\u0000\u0000\u0000\u0000Thomas NJ, Lynam AL, Hill AV, Weedon MN, Shields BM, Oram RA, McDonald\n",
      "TJ, Hattersley AT, Jones AG. Type 1 diabetes de\u0000ned by severe insulin...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6578\n",
      "Documento: diabetes 3c. \n",
      "Frequentemente este tipo de DM cursa com rápida deterioração da função de\n",
      "células ß pancreáticas e labilidade do controle glicêmico.\n",
      "Nota importante 9\u0000 Diabetes secundário\n",
      "No caso de dúvidas quanto à classi\u0000cação de DM, deve ser sempre\n",
      "considerado a presença de sinais e sintomas relacionados a doenças do\n",
      "pâncreas exócrino (alcoolismo, cirurgia), uso de medicações\n",
      "hiperglicemiantes, endocrinopatias (acromegalia, síndrome de Cushing),...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6538\n",
      "Documento: por ser superior e mais prático do que o TTGO-2h.\n",
      "ClasseI NívelB\n",
      "Sumário de evidências:\n",
      "Em 1979, o National Diabetes Data Group (NDDG) recomendava valores\n",
      "intermediários de glicemia durante o TTGO-2h (30 min, 1 hora e 1 hora e 30\n",
      "min) para diagnóstico de DM. Devido à baixa praticidade de execução dessas\n",
      "medidas intermediárias e à observação de que a medida de 2 horas obteve\n",
      "reprodutibilidade e sensibilidade satisfatórias para diagnosticar DM2, os...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6523\n",
      "Documento: dos níveis de HbA1c mostrou ser importante na detecção do diabetes\n",
      "induzido por glicocorticoide.⁶⁷ \n",
      "O uso de antipsicóticos tem sido associado ao risco de DM através de\n",
      "mecanismos diretos (alteração da sensibilidade e da secreção de insulina) ou\n",
      "indiretos (ganho de peso). Os fármacos mais associados a esse risco são:\n",
      "clorpromazina (primeira geração), clozapina, olanzapina, quetiapina e\n",
      "risperidona (segunda geração).⁶⁸ ...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6515\n",
      "Documento: \u0000\u0000\u0000\u0000Stenström G, Gottsäter A, Bakhtadze E, Berger B, Sundkvist G. Latent\n",
      "autoimmune diabetes in adults: de\u0000nition, prevalence, beta-cell function, and\n",
      "treatment. Diabetes. 2005 Dec;54 (Suppl 2):S68-72. \n",
      "\u0000\u0000\u0000\u0000Sia HK, Tu ST, Liao PY, Lin KH, Kor CT, Yeh LL.  Share. A convenient\n",
      "diagnostic tool for discriminating adult-onset glutamic acid decarboxylase\n",
      "antibody-positive autoimmune diabetes from type 2 diabetes: a retrospective\n",
      "study. PeerJ. 2020 Feb 14;8\u0000e8610....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6508\n",
      "Documento: anteriores. Níveis de HbA1c próximos à 7% correspondem a glicemias médias\n",
      "diárias de aproximadamente 154 mg/dL, variando de 122 a 184 mg/dl, e tem\n",
      "sido considerados como referência para a meta mais usada no controle do\n",
      "diabetes. A glicemia média diária estimada também pode ser obtida através da\n",
      "média dos dados dos glicosímetros com softwares próprios, sendo estas, mais\n",
      "\u0000dedignas, tanto quanto mais frequentes forem as aferições diárias. Para...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6493\n",
      "Documento: children and adolescents. Curr Diabetes Rev. 2020;16(3)\u0000220–9.\n",
      "\u0000\u0000\u0000\u0000Harjutsalo V, Reunanen A, Tuomilehto J. Differential transmission of type 1\n",
      "diabetes from diabetic fathers and mothers to their offspring. Diabetes. 2006\n",
      "May 1;55(5)\u00001517–24. \n",
      "\u0000\u0000\u0000\u0000Warram JH, Krolewski AS, Gottlier MS, Kahn R. Differences in risk of insulin-\n",
      "dependent diabetes in offspring of diabetic mothers and diabetic fathers. N\n",
      "Engl J Med. 1984;311\u0000149–52....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6493\n",
      "Documento: grupo de tratamento convencional da época.\n",
      "Alvos mais rigorosos de HbA1c foram avaliados em três ensaios clínicos\n",
      "randomizados incluindo pessoas acima de 60 anos de idade e com mais\n",
      "tempo de diabetes: ADVANCE (Action in Diabetes and Vascular Disease:\n",
      "Preterax and Diamicron modi\u0000ed release controlled evaluation), ACCORD\n",
      "(Action to Control Cardiovascular Risk in Diabetes) e VADT (Veterans Affair\n",
      "Diabetes Trial).\n",
      "Os estudos ADVANCE (n = 11.140), ACCORD (n = 10.251) e VADT (n = 1.791)...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6491\n",
      "Documento: levando em conta o alto custo, a incidência da doença no país e a\n",
      "ausência de medicações imunomoduladoras aprovadas pela\n",
      "ANVISA.\n",
      "Quadro 5. Fases do diabetes mellitus tipo 1\n",
      "Fase Características\n",
      "Fase 1* 2 ou mais anticorpos positivos, porém sem alterações glicêmicas;assintomático\n",
      "Fase 2* 2 ou mais anticorpos positivos, com disglicemia leve, porém sem critériospara diabetes; assintomático\n",
      "Fase 3 Anticorpos positivos, e hiperglicemia com critérios para diabetes;sintomático\n",
      "*Fases pré-clínicas...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6489\n",
      "Documento: Rancho Bernardo Study. Diabetes Care. 2010 Jan 1;33(1)\u0000101–3. \n",
      "\u0000\u0000\u0000\u0000Bennett CM, Guo M, Dharmage SC. HbA1c as a screening tool for detection of\n",
      "type 2 diabetes: a systematic review. Diabet Med. 2007 Abr;24(4)\u0000333–43. \n",
      "\u0000\u0000\u0000\u0000do Vale Moreira NC, Montenegro RM, Meyer HE, Bhowmik B, Mdala I,\n",
      "Siddiquee T, et al. Glycated hemoglobin in the diagnosis of diabetes mellitus\n",
      "in a semi-urban Brazilian population. Int J Environ Res Public Health. 2019 Sep\n",
      "26;16(19)\u00003598....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6486\n",
      "Documento: 10.1371/journal.pone.0154411.\n",
      "\u0000\u0000\u0000Ito C, Maeda R, Ishida S, Harada H, Inoue N, Sasaki H. Importance of OGTT for\n",
      "diagnosing diabetes mellitus based on prevalence and incidence of\n",
      "retinopathy. Diabetes Res Clin Pract.  2000 Aug;49(2–3)\u0000181–6.\n",
      "\u0000\u0000\u0000McCance DR, Hanson RL, Charles MA, Jacobsson LTH, Pettitt DJ, Bennett PH,\n",
      "et al. Comparison of tests for glycated haemoglobin and fasting and two-hour\n",
      "plasma glucose concentrations as diagnostic methods for diabetes. BMJ.\n",
      "1994;308\u00001323–8....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6452\n",
      "Documento: I B\n",
      "R9 - Em pacientes não-gestantes com DM1, É RECOMENDADOque a variabilidade glicêmica, medida através do cálculo docoe\u0000ciente de variação deva ser < 36%, obtido através dedispositivos de monitorização contínua de glicose ou valores deglicemia capilar.\n",
      "I C\n",
      "Referências\n",
      "1. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, et al.\n",
      "Translating the A1C assay into estimated average glucose values. Diabetes Care.\n",
      "2008 Aug;31(8)\u00001473–8....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6445\n",
      "Documento: No diabetes tipo 2, o controle intensivo da glicemia diminuiu os desfechos\n",
      "cardiovasculares a longo prazo quando adotados em pacientes com diabetes\n",
      "recém diagnosticados.Em uma subanálise 10 anos após o estudo UKPDS ter\n",
      "\u0000nalizado, 3277 pacientes com DM2 foram reavaliados. Foi observada redução\n",
      "no risco de IAM em 15% e morte por todas as causas em 13% no grupo que\n",
      "havia participado do grupo de tratamento intensivo em comparação com o\n",
      "grupo de tratamento convencional da época....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6425\n",
      "Documento: HbA1c for cost-effective screening. Diabetes Care. 2003 Feb 1;26(2)\u0000485–90.\n",
      "\u0000\u0000\u0000\u0000Chatterjee R, Venkat Narayan KM, Lipscomb J, Phillips LS. Screening adults\n",
      "for pre-diabetes and diabetes may be cost-saving. Diabetes Care. 2010 Jul\n",
      "1;33(7)\u00001484–90. \n",
      "\u0000\u0000\u0000\u0000Wilmot EG, Edwardson CL, Biddle SJ, Gorely T, Henson J, Khunti K, et al.\n",
      "Prevalence of diabetes and impaired glucose metabolism in younger ‘at risk’\n",
      "UK adults: insights from the STAND programme of research. Diabet Med. 2013\n",
      "Jun;30(6)\u0000671–5....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6414\n",
      "Documento: R1 - É RECOMENDADA a meta de HbA1c < 7,0% para todos osindivíduos com diabetes, para prevenção de complicaçõesmicrovasculares, desde que não incorra em hipoglicemias gravese frequentes.\n",
      "I A\n",
      "R2 - É RECOMENDADA a meta de HbA1c < 7,0% para todos osindivíduos com diabetes, para prevenção de complicaçõesmacrovasculares em longo prazo, desde que não incorra emhipoglicemias graves e frequentes.\n",
      "I B...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6414\n",
      "Documento: dependent diabetes mellitus. N Engl J Med. 1989;321(6)\u0000337–43.\n",
      "\u0000\u0000\u0000\u0000Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ. Type 2\n",
      "diabetes in children and adolescents. Pediatr Diabetes 2009;10(Suppl. 12)\u000017-\n",
      "32.\n",
      "\u0000\u0000\u0000\u0000Magge SN, Stettler N, Jawad AF, Levitt Katz LE. Increased prevalence of\n",
      "abnormal glucose tolerance among obese siblings of children with type 2\n",
      "diabetes. J Pediatr. 2009;154(4)\u0000562–6.e1.\n",
      "\u0000\u0000\u0000\u0000Eyzaguirre F, Bancalari R, Román R, Silva R, Youlton R, Urquidi C, et al....\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6388\n",
      "Documento: study. PeerJ. 2020 Feb 14;8\u0000e8610.\n",
      "\u0000\u0000\u0000\u0000Fourlanos S, Perry C, Stein MS, Stankovich J, Harrison LC, Colman PG. A\n",
      "clinical screening tool identi\u0000es autoimmune diabetes in adults. Diabetes\n",
      "Care. 2006 May;29(5)\u0000970-5. \n",
      "\u0000\u0000\u0000\u0000Hattersley AT, Greeley SAW, Polak M, Rubio-Cabezas O, Njølstad PR,\n",
      "Mlynarski W, Castano L, Carlsson A, Raile K, Chi DV, Ellard S, Craig ME. ISPAD\n",
      "Clinical Practice Consensus Guidelines 2018\u0000 The diagnosis and management...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6382\n",
      "Documento: mellitus. Clin Pediatr (Phila). 1998;37(2)\u000073–9.\n",
      "\u0000\u0000\u0000\u0000Shield JP, Lynn R, Wan KC, Haines L, Barrett TG. Management and 1 year\n",
      "outcome for UK children with type 2 diabetes. Arch Dis Child.\n",
      "2009;94(3)\u0000206–9. \n",
      "\u0000\u0000\u0000\u0000Hannon TS, Arslanian SA. The changing face of diabetes in youth: lessons\n",
      "learned from studies of type 2 diabetes. Ann N Y Acad Sci. 2015;1353\u0000113–37. \n",
      "\u0000\u0000\u0000\u0000Valaiyapathi B, Gower B, Ashraf AP. Pathophysiology of type 2 diabetes in...\n",
      "--------------------------------------------------\n",
      "Similaridade: 0.6381\n",
      "Documento: \u0000\u0000\u0000\u0000Phillip M, Achenbach P, Addala A, Albanese-O’Neill A, Battelino T, Bell KJ, et al.\n",
      "Consensus guidance for monitoring individuals with islet autoantibody-\n",
      "positive pre-stage 3 type 1 diabetes. Diabetes Care. 2024 Jun 24\u0000dci240042.\n",
      "doi: 10.2337/dci24-0042.\n",
      "Cite este artigo\n",
      "Melanie Rodacki, Roberta A. Cobas, Lenita Zajdenverg, Wellington Santana da\n",
      "Silva Júnior, Luciano Giacaglia, Luis Eduardo Calliari, Renata Maria Noronha,...\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "#Implementando uma busca personalizada\n",
    "#Baseando-se na busca de similaridade por cosseno , para mais detalhes: https://pt.wikipedia.org/wiki/Produto_escalar\n",
    "#Tem esse estudo falando sobre o problema deste método que é interessante: https://www.shaped.ai/blog/cosine-similarity-not-the-silver-bullet-we-thought-it-was\n",
    "def cosine_similarity(v1, v2):\n",
    "    return np.dot(v1, v2) / (np.linalg.norm(v1) * np.linalg.norm(v2))\n",
    "\n",
    "# Calcular similaridade entre a consulta e todos os documentos\n",
    "similarities = [cosine_similarity(query_embedding,doc_embedding) for doc_embedding in embeddings]\n",
    "# Ordenar os índices dos documentos pela similaridade de forma decrescente\n",
    "sorted_indices = np.argsort(similarities)[::-1]\n",
    "\n",
    "# Obter os documentos mais semelhantes (top 5)\n",
    "top_k = 100\n",
    "top_docs = [texts[i] for i in sorted_indices[:top_k]]\n",
    "top_similarities = [similarities[i] for i in sorted_indices[:top_k]]\n",
    "top_embeddings = [embeddings[i] for i in sorted_indices[:top_k]]\n",
    "# Exibir os resultados\n",
    "for doc, sim in zip(top_docs, top_similarities):\n",
    "    print(f\"Similaridade: {sim:.4f}\")\n",
    "    print(f\"Documento: {doc[:1000]}...\")  # Exibir os primeiros 200 caracteres do documento\n",
    "    print(\"-\" * 50)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plotar os vetores em 2D com PCA\n",
    "pca = PCA(n_components=2)\n",
    "points_2d = pca.fit_transform(np.array(top_embeddings + [query_embedding]))\n",
    "\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# Plotar documentos\n",
    "for i in range(top_k):\n",
    "    plt.scatter(*points_2d[i], color='blue')\n",
    "    plt.text(points_2d[i][0], points_2d[i][1], f'Doc {i+1}', color='blue', fontsize=9)\n",
    "\n",
    "# Plotar consulta\n",
    "plt.scatter(*points_2d[-1], color='red', marker='X', s=100, label='Consulta')\n",
    "plt.text(points_2d[-1][0], points_2d[-1][1], 'Consulta', color='red', fontsize=10)\n",
    "\n",
    "plt.title(\"Visualização 2D dos embeddings mais semelhantes\")\n",
    "plt.xlabel(\"PCA 1\")\n",
    "plt.ylabel(\"PCA 2\")\n",
    "plt.grid(True)\n",
    "plt.legend()\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Dados para consulta: \u0000\u0000\u0000\u0000Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for\n",
      "the classi\u0000cation and prediction of diabetes. Diabetes Care. 2011 Jan;34(1)\u000084-\n",
      "9. doi: 10.2337/dc10-1235. \n",
      "\u0000\u0000\u0000\u0000Kumar PR, Bhansali A, Ravikiran M, Bhansali S, Dutta P, Thakur JS, et al. Utility\n",
      "of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-\n",
      "based study. J Clin Endocrinol Metab. 2010 Jun 1;95(6)\u00002832–5. \n",
      "\u0000\u0000\u0000\u0000Kramer CK, Araneta MRG, Barrett-Connor E. A1C and diabetes diagnosis: The\n",
      "Responda sobre: Principais Tipos de Diabetes\n",
      " Os artigos citados discutem a utilização da hemoglobina glicada (HbA1c) em diagnóstico e previssão de diabetes, além de estudar sua utilidade em diferentes contextos.\n",
      "\n",
      "O primeiro estudo, conduzido por Selvin et al., publicado no Diabetes Care em 2011, avaliou a performance da HbA1c na classificação e predição de diabetes, utilizando dados do Exame Nacional de Saúde e Nutrição. Os resultados mostraram que a HbA1c tem boa sensibilidade e especificidade para identificar casos de diabetes tipo 2 não diagnósticos.\n",
      "\n",
      "O segundo estudo, conduzido por Kumar et al., publicado no Journal of Clinical Endocrinology & Metabolism em 2010, avaliou a utilidade da HbA1c na diagnóstico de diabetes tipo 2 mellitus utilizando dados de uma amostra comunitaria. Os resultados mostraram que a HbA1c é um teste confiável para identificar casos de diabetes tipo 2 não diagnosticados e também pode ser utilizado como um teste rápido para diagnóstico pré-clínico da diabetes tipo 2.\n",
      "\n",
      "O terceiro artigo, cujos autores são Kramer et al., avalia a utilidade do A1C na diagnóstico de diabetes, mas não é claro se essa publicação está relacionada ao contexto dos outros artigos citados.\n"
     ]
    }
   ],
   "source": [
    "#Chamar a IA com o prompt + contexto do RAG\n",
    "prompt_final = \"Dados para consulta: \" + texts[sorted_indices[0]] + \"\\nResponda sobre: \" + query\n",
    "\n",
    "print(prompt_final)\n",
    "client = Client()\n",
    "response = client.chat(\n",
    "    model='mistral',\n",
    "    messages=[\n",
    "       \n",
    "        {\"role\": \"user\", \"content\": prompt_final},\n",
    "        \n",
    "    ]\n",
    ")\n",
    "\n",
    "print(response['message']['content'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "colab": {
   "provenance": []
  },
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
